MoneyWorks4Me

Glenmark Pharmaceuticals shareholders approves dividend

04 Aug 2012 Evaluate
Glenmark Pharmaceuticals has informed that at the annual general meeting (AGM) held on August 03, 2012, the shareholders have approved the dividend of Rs. 2 per share of Rs. 1 each (200%) on the equity share capital of the company for the financial year ended 2011-12.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..